| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $54.09 | 09 Dec 2025 | Direct |
| Akero Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $54.09 | 09 Dec 2025 | Indirect |
| Stoke Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 29,747 | 03 Jun 2025 | Direct | ||
| Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 9 | $0 | 4 | Director | 09 Dec 2025, 10:21 |
| AKRO | Akero Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:06 |
| STOK | Stoke Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 04 Jun 2025, 20:33 |
| AKRO | Akero Therapeutics, Inc. | 08 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 17:22 |
| STOK | Stoke Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:32 |
| AKRO | Akero Therapeutics, Inc. | 23 Jun 2023 | 1 | $0 | 4 | Director | 27 Jun 2023, 17:48 |
| STOK | Stoke Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:23 |
| AKRO | Akero Therapeutics, Inc. | 30 Nov 2022 | 4 | -$1,085,739 | 4 | Director | 02 Dec 2022, 16:48 |
| AKRO | Akero Therapeutics, Inc. | 28 Oct 2022 | 4 | -$1,777,829 | 4 | Director | 01 Nov 2022, 17:38 |
| AKRO | Akero Therapeutics, Inc. | 25 Oct 2022 | 14 | -$12,193,196 | 4 | Director | 27 Oct 2022, 21:50 |
| STOK | Stoke Therapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 17:00 |
| AKRO | Akero Therapeutics, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:25 |
| STOK | Stoke Therapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 25 Jun 2021, 16:57 |
| AKRO | Akero Therapeutics, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 17:56 |